Organicell Reports Interim Results of Phase 1/2A Research Program

Organicell Reports Interim Results of Phase 1/2A Research Program

Related Keywords

Harry Leider ,Jacqueline Domenech ,Howard Golub ,Organicell Regenerative Medicines Inc ,Securities Exchange ,Organicell Regenerative Medicine Inc ,News Network ,Organicell Regenerative Medicine ,Chief Science Officer ,Chief Executive Officer ,Organicell Regenerative Medicines ,Regenerative Medicine ,Looking Statements ,Securities Act ,Securities Exchange Act ,Private Securities Litigation Reform Act ,Media Relations Contact ,Investor Relations ,